Skip to main
University-wide Navigation

Markey’s Community Advisory Board advocates for research advances

The CAB meets regularly throughout the year to offer input on the Kentucky Cancer Needs Assessment, Markey’s strategic plan, research priorities and outreach activities.

Markey researchers present findings at world’s largest oncology meeting

Physicians and scientists from the UK Markey Cancer Center will share their latest research at the American Society of Clinical Oncology’s annual meeting in Chicago from May 30 to June 3.

Ky. attorney defies brain cancer odds through Markey clinical trial

Following surgery to remove a tumor from his brain, David Higdon was offered the opportunity to participate in an NIH-funded clinical trial.

Research Advancing Kentucky: Propelling the science behind cancer care

Researchers at the University of Kentucky play an important role in advancing the health, well-being and future of our Commonwealth.   Much of that work is done with support from the National Institutes of Health (NIH). That support allows our researchers to find answers to many of the critical health issues facing Kentuckians.  

Markey research team discovers gut hormone’s role in fatty liver disease

UK Markey Cancer Center researchers have identified a mechanism by which a gut hormone contributes to fatty liver disease, offering potential new targets for treating the common condition.

Research Advancing Kentucky: Providing hope to pediatric cancer patients

With NIH support, John D’Orazio combines his research with active clinical practice, treating pediatric patients with cancer and blood disorders.

Markey reaches 10,000 patient milestone in national cancer research network

The UK Markey Cancer Center has enrolled its 10,000th patient in the Oncology Research Information Exchange Network (ORIEN) since joining the alliance in 2017.

Markey researchers to present groundbreaking cancer findings at AACR meeting

At the annual gathering of cancer experts, the UK Markey Cancer Center team will present studies with the potential to significantly transform cancer care.

UK study reveals key mechanism behind prostate cancer drug resistance, potential new treatment strategy

A team of UK Markey Cancer Center researchers has found the mechanism that grants prostate cancer resistance to enzalutamide, a frequently used drug.

Plant-based coffee yields promising results in Markey ovarian cancer trial

Recent research shows that a commercially available decaffeinated coffee product containing a controlled dose of Artemisia annua may have anti-cancer properties.